CervoMed Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CervoMed Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • CervoMed Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.4M, a 102% decline year-over-year.
  • CervoMed Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$13.5M, a 1602% decline year-over-year.
  • CervoMed Inc. annual Operating Income (Loss) for 2023 was -$7.81M, a 125% decline from 2022.
  • CervoMed Inc. annual Operating Income (Loss) for 2022 was -$3.48M, a 85.9% increase from 2021.
  • CervoMed Inc. annual Operating Income (Loss) for 2021 was -$24.7M, a 54.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$13.5M -$5.4M -$2.72M -102% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$10.7M -$3M -$1.76M -143% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$8.98M -$2.59M -$1.17M -81.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$7.81M -$2.48M -$8.71M -140% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $896K -$2.68M -$1.77M -196% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $2.67M -$1.23M +$3.01M +71% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$347K -$1.43M +$3.13M +68.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$3.48M $6.23M +$9.69M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$13.2M -$904K +$11.8M +92.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$25M -$4.25M -$413K -10.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$24.5M -$4.55M +$130K +2.77% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$24.7M -$3.47M +$6.53M +65.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 -$31.2M -$12.7M -$7.42M -141% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$23.8M -$3.83M -$175K -4.78% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$23.6M -$4.68M -$7.64M -259% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$16M -$10M -$7.04M -238% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 -$8.94M -$5.27M -$2.22M -72.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$6.71M -$3.66M -$1.04M -39.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$5.68M $2.96M +$5.87M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$11.6M -$2.96M +$2.6M +46.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-17
Q3 2019 -$14.1M -$3.05M +$3.92M +56.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$18.1M -$2.62M +$457K +14.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$18.5M -$2.92M +$433K +12.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$19M -$5.56M -$3.1M -126% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-17
Q3 2018 -$15.9M -$6.97M -$3.63M -108% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$12.2M -$3.08M -$97.2K -3.26% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$12.1M -$3.35M -$784K -30.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$11.3M -$2.45M +$94.8K +3.72% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-19
Q3 2017 -$11.4M -$3.35M +$2.45M +42.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$13.9M -$2.98M +$819K +21.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$14.7M -$2.57M +$3.66M +58.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$18.4M -$2.55M +$20.6K +0.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$18.4M -$5.8M -$4.45M -331% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$13.9M -$3.8M -$2.5M -193% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$11.4M -$6.22M -$5.03M -422% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$6.41M -$2.57M +$5.36M +67.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$11.8M -$1.35M +$2.17M +61.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$13.9M -$1.3M +$504K +28% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$14.4M -$1.19M +$179K +13% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$14.6M -$7.93M -$6.99M -741% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 -$7.63M -$3.51M -$1.85M -111% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$5.78M -$1.8M +$6.3M +77.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$12.1M -$1.37M +$721K +34.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$12.8M -$943K +$1.64M +63.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-03
Q3 2013 -$14.4M -$1.66M +$1.76M +51.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$16.2M -$8.1M -$4.67M -136% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$11.5M -$2.09M +$260K +11% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 -$11.8M -$2.59M Oct 1, 2012 Dec 31, 2012 10-K/A 2014-04-23
Q3 2012 -$3.43M +$714K +17.2% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-19
Q2 2012 -$3.43M -$1.37M -66.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-11-19
Q1 2012 -$2.35M Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-05-20
Q3 2011 -$4.14M -$2.5M -152% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q2 2011 -$2.06M -$237K -13% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-07
Q3 2010 -$1.64M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$1.82M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.